top of page
Picture1_upscaled.jpg

Gloryn Chia Lab

"Join the fight against cancer — pioneer the future of immunotherapy with us"

Gloryn-Chia-1c.jpg

Principal Investigator

Assistant Professor Gloryn CHIA

Assistant Professor Gloryn Chia is a faculty member in the Department of Pharmacy at the National University of Singapore (NUS). She leads a research program focused on developing novel vaccines and stem cell therapies for the treatment of cancer and other human diseases. Her work particularly emphasizes personalized neoantigen vaccines, which are emerging as a promising class of immunotherapy. By harnessing new genomic technologies, her team aims to improve the efficacy of these vaccines and translate research findings into clinical practice for personalized cancer treatment. 

Publications

Picture2_edited.jpg

To explore our publications and see how we are showcasing our ongoing efforts in this exciting and evolving field, click the “Read More” button.

Our Research

Neoantigen Therapy

Neoantigen Therapy

Develop a pipeline to identify and validate neoantigens for personalized vaccines and TCR therapies, and discover new shared alternative neoantigens across cancer patients.

Immunotherapy

Immunotherapy 

Identify and characterize immunotherapy targets, and develop therapeutic agents to enhance immune-mediated recognition and elimination of cancer cells

Tumor Biology

Tumor Biology

Elucidate mechanisms of immune dysfunction in drug-resistant cancers.

Team Members

Alumni

eba61101-0173-40f5-8756-d52a417cebc5.jpg

Dinner at Our PI’s House -

A Night to Remember!

🍽️✨

Acknowledgement

We gratefully acknowledge the generous support provided by our past and present funders

image.png
image_edited.png
image.png
image.png
image.png
image.png
image.png

​Upcoming Events

GC lab

Business Hour 

Location

Mon - Fri                     9 am - 6pm

Weekend                      Closed

Public Holiday            Closed

Address

NUS S9 Building,

4 Science Drive 2,

Singapore 117544. 

JOIN US

NOW!

bottom of page